News
TD Cowen Downgrades Fusion Pharmaceuticals to Hold
16 Apr 24
News, Downgrades, Analyst Ratings
AstraZeneca Hikes Annual Dividend By 7% Just Before Vote On Its CEO's Pay Package Boost
11 Apr 24
Biotech, Large Cap, News, Dividends, Health Care, Movers, Trading Ideas, General
AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race
2 Apr 24
Biotech, Large Cap, News, Health Care, General
RBC Capital Reiterates Sector Perform on Fusion Pharmaceuticals, Maintains $21 Price Target
21 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Wedbush Reiterates Neutral on Fusion Pharmaceuticals, Maintains $24 Price Target
21 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Recap: Fusion Pharmaceuticals Q4 Earnings
20 Mar 24
Earnings
Fusion Pharmaceuticals Q4 2023 GAAP EPS $(0.39) Misses $(0.34) Estimate
20 Mar 24
Earnings, Earnings Misses, News
Raymond James Downgrades Fusion Pharmaceuticals to Market Perform
20 Mar 24
News, Downgrades, Analyst Ratings
B. Riley Securities Downgrades Fusion Pharmaceuticals to Neutral, Raises Price Target to $23
20 Mar 24
News, Downgrades, Price Target, Analyst Ratings
Truist Securities Downgrades Fusion Pharmaceuticals to Hold, Raises Price Target to $21-REPORT RELEASED ON 19TH MARCH 2024
20 Mar 24
News, Downgrades, Price Target, Analyst Ratings
Unveiling 11 Analyst Insights On Fusion Pharmaceuticals
20 Mar 24
Analyst Ratings
RBC Capital Downgrades Fusion Pharmaceuticals to Sector Perform, Raises Price Target to $21
20 Mar 24
News, Downgrades, Price Target, Analyst Ratings
JonesTrading Downgrades Fusion Pharmaceuticals to Hold
20 Mar 24
News, Downgrades, Analyst Ratings
Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results
19 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
19 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Intraday Session
19 Mar 24
Movers
Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results
19 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
William Blair Downgrades Fusion Pharmaceuticals to Market Perform
19 Mar 24
News, Downgrades, Analyst Ratings
Brookline Capital Downgrades Fusion Pharmaceuticals to Hold
19 Mar 24
News, Downgrades, Analyst Ratings
Raymond James Downgrades Fusion Pharmaceuticals to Market Perform
19 Mar 24
News, Downgrades, Analyst Ratings
Press releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HMST, CHX, FUSN, DRQ
12 Apr 24
News, Legal, Press Releases
Kuehn Law Encourages HMST, CHX, FUSN, and DRQ Investors to Contact Law Firm
12 Apr 24
News, Legal, Press Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, JBT
9 Apr 24
Press Releases
Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024
9 Apr 24
Press Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, DOMA
5 Apr 24
Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ADTH, LABP, FUSN
1 Apr 24
News, Legal, Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DRQ, FUSN, LABP, FXNC
27 Mar 24
News, Legal, Press Releases
INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Fusion Pharmaceuticals Inc. - FUSN
26 Mar 24
Small Cap, Press Releases
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FUSN, DRQ, X
21 Mar 24
Press Releases
Kuehn Law Encourages DRQ, EVBG, FREE, and FUSN Investors to Contact Law Firm
20 Mar 24
Press Releases
Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates
20 Mar 24
Earnings, Press Releases
FUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSN
19 Mar 24
Press Releases
FUSN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Fusion Pharmaceuticals Inc. Is Fair to Shareholders
19 Mar 24
Press Releases
Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6 Mar 24
Press Releases
Fusion Pharmaceuticals to Present Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the 2024 AACR Annual Meeting
5 Mar 24
Press Releases
Fusion Pharmaceuticals Enters into Exclusive Worldwide License Agreement with Heidelberg University and Euratom for Actinium-Based PSMA Targeted Radiotherapy
16 Feb 24
Press Releases
Fusion Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
7 Feb 24
Press Releases
Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6 Feb 24
Press Releases